DE60113380D1 - Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2 - Google Patents

Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2

Info

Publication number
DE60113380D1
DE60113380D1 DE60113380T DE60113380T DE60113380D1 DE 60113380 D1 DE60113380 D1 DE 60113380D1 DE 60113380 T DE60113380 T DE 60113380T DE 60113380 T DE60113380 T DE 60113380T DE 60113380 D1 DE60113380 D1 DE 60113380D1
Authority
DE
Germany
Prior art keywords
foxc2
human
gene
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60113380T
Other languages
English (en)
Other versions
DE60113380T2 (de
Inventor
Sven Enerbaeck
Peter Carlsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LEANGENE GOETEBORG AB
Original Assignee
LEANGENE GOETEBORG AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0000531A external-priority patent/SE0000531D0/xx
Priority claimed from SE0001982A external-priority patent/SE0001982D0/xx
Priority claimed from US09/587,945 external-priority patent/US6709860B1/en
Priority claimed from SE0004629A external-priority patent/SE0004629D0/xx
Application filed by LEANGENE GOETEBORG AB filed Critical LEANGENE GOETEBORG AB
Publication of DE60113380D1 publication Critical patent/DE60113380D1/de
Application granted granted Critical
Publication of DE60113380T2 publication Critical patent/DE60113380T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE60113380T 2000-02-18 2001-02-16 Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2 Expired - Fee Related DE60113380T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
SE0000531 2000-02-18
SE0000531A SE0000531D0 (sv) 2000-02-18 2000-02-18 Animal model
SE0001982 2000-05-26
SE0001982A SE0001982D0 (sv) 2000-05-26 2000-05-26 Animal model
US09/587,945 US6709860B1 (en) 1997-05-26 2000-06-06 Animal model
US587945 2000-06-06
SE0004629A SE0004629D0 (sv) 2000-12-14 2000-12-14 Animal model III
SE0004629 2000-12-14
PCT/SE2001/000339 WO2001060853A1 (en) 2000-02-18 2001-02-16 Transgenic animal model for obesity expressing foxc2

Publications (2)

Publication Number Publication Date
DE60113380D1 true DE60113380D1 (de) 2005-10-20
DE60113380T2 DE60113380T2 (de) 2006-06-29

Family

ID=27484514

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60113380T Expired - Fee Related DE60113380T2 (de) 2000-02-18 2001-02-16 Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2

Country Status (11)

Country Link
EP (1) EP1255774B1 (de)
JP (1) JP2003523192A (de)
AT (1) ATE304552T1 (de)
AU (2) AU3259901A (de)
CA (1) CA2400342A1 (de)
DE (1) DE60113380T2 (de)
IL (1) IL150951A0 (de)
IS (1) IS6502A (de)
NO (1) NO20023709L (de)
NZ (1) NZ521005A (de)
WO (1) WO2001060853A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002027008A1 (en) * 2000-09-26 2002-04-04 Biovitrum Ab Promoter sequences
WO2003064467A1 (en) * 2002-01-29 2003-08-07 Biovitrum Ab A complex of a human foxc2 protein and a foxc2-interacting protein
WO2005012570A1 (ja) * 2003-07-31 2005-02-10 Banyu Pharmaceutical Co., Ltd. Slc25a10による肥満治療に有効な化合物の評価方法
DE602004019451D1 (de) * 2003-12-03 2009-03-26 Whitehead Biomedical Inst Verwendung von löslichem T-Cadherin zur Behandlung von Stoffwechselkrankheiten
SE0400489D0 (sv) * 2004-02-27 2004-02-27 Biovitrum Ab Therapeutic proteins
KR101669140B1 (ko) * 2015-04-28 2016-10-26 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006104A1 (en) * 1990-09-28 1992-04-16 The Dana-Farber Cancer Institute Adipocyte-specific dna sequences and use for the production of transgenic animals exhibiting altered fat metabolism
SE9701963D0 (sv) * 1997-05-26 1997-05-26 Pharmacia & Upjohn Ab Novel transcription factor
US6087107A (en) * 1998-04-15 2000-07-11 The University Of Iowa Research Foundation Therapeutics and diagnostics for congenital heart disease based on a novel human transcription factor

Also Published As

Publication number Publication date
JP2003523192A (ja) 2003-08-05
WO2001060853A1 (en) 2001-08-23
AU3259901A (en) 2001-08-27
IS6502A (is) 2002-08-14
CA2400342A1 (en) 2001-08-23
IL150951A0 (en) 2003-02-12
ATE304552T1 (de) 2005-09-15
AU2001232599B2 (en) 2006-10-12
NO20023709L (no) 2002-10-17
DE60113380T2 (de) 2006-06-29
NZ521005A (en) 2004-04-30
EP1255774B1 (de) 2005-09-14
EP1255774A1 (de) 2002-11-13
NO20023709D0 (no) 2002-08-06

Similar Documents

Publication Publication Date Title
Bryant et al. Intrinsic and extrinsic control of growth in developing organs
ATE455552T1 (de) Expression des active human factor ix im brustdrüsengewebe transgener tiere
US20070299472A1 (en) System and Method of Up-Regulating Bone Morphogenetic Proteins (Bmp) Gene Expression in Bone Cells Via the Application of Fields Generated by Specific and Selective Electric and Electromagnetic Signals
KR20090029749A (ko) 특이적이고 선택적인 전기장 및 전자기장의 인가를 통한 생세포에서의 전환 성장 인자-베타 (ＴＧＦ-β) 유전자 발현의 조절
US20090209020A1 (en) collagenous matrix with improved porosity and tensile strength and preparation method therefore by using mechanical stimulation system
DE60226335D1 (en) Aviäres expressionssystem für fremdproteine
Handler et al. Regulation of vitellogenin synthesis in Drosophila by ecdysterone and juvenile hormone
Gardner et al. Differential fracture healing resulting from fixation stiffness variability: a mouse model
DE60113380D1 (de) Methoden zur identifizierung von zusammensetzungen, die für die behandlung von fettleibigkeit nützlich sind, unter verwendung von foxc2
Luo et al. Ex ovo electroporation for gene transfer into older chicken embryos
DE69832798D1 (de) Regulatorische sequenzen für die in-vivo-expression einer heterologen dns-sequenz in endothelzellen und ihre verwendungen.
AU2009212561B2 (en) Regulation of Fibroblastic Growth Factor-2 (FGF-2) gene expression in living cells with the application of specific and selective electric an electromagnetic fields
EP1799709A4 (de) Myostatin-isoform
CN111187845A (zh) Fgf21基因在产毛动物选育和/或调节毛发长短中的应用
Assailly et al. Effect of weak inductively coupled pulsating currents on calcium uptake in embryonic chick tibia explants
Rapoport et al. An extended model of the glycolysis in erythrocytes
Yang et al. Red deer antler extract accelerates hair growth by stimulating expression of insulin-like growth factor I in full-thickness wound healing rat model
FR2771102B1 (fr) Procede pour induire la differenciation osteoblastique de cellules de tissu adipeux extramedullaire humain
KR20030024028A (ko) 혈관신생조절 유전자가 삽입된 줄기세포를 이용한무혈성골괴사의 치료
ATE447415T1 (de) Ghrh zur verwendung bei der behandlung von chronischer niereninsuffizienz
Watanuki et al. Effect of low-intensity pulsed ultrasound on scaffold-free ectopic bone formation in skeletal muscle
ATE438715T1 (de) Verwendung von molekularbiologisch hergestellten, nicht-viralen wirkstoffen zur behandlung der akne
Kao et al. Osteogenic gene expression of murine osteoblastic (MC3T3-E1) cells under cyclic tension
Jimenez-Rojo et al. Tissue recombination and kidney capsule transplantation assays for the study of epithelial-mesenchymal interactions
Jones On the nature of Biological Clocks?

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee